Reviva Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
CUPERTINO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
News
Apexigen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
SAN CARLOS, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
G1 Therapeutics to Participate Virtually in the H.C. Wainwright 24th Annual Global Investment Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
AmMax Bio Announces AMB-05X Granted FDA Fast Track Designation for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
Proof-of-Concept Established in Phase 2 Trial of TGCT, with Positive Efficacy Results Across Multiple Clinical…
Madrigal Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
CONSHOHOCKEN, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage…
Capricor Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company…
Recce Pharmaceuticals Appoints Alistair McKeough to its Board of Directors
Industry veteran strengthens Recce’s Board of Directors with significant operating experience SYDNEY, Australia, Sept. 07,…
Jounce Therapeutics to Participate in the Upcoming Investor Conferences
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
Ashvattha Therapeutics Announces First Patient Enrolled in a Phase 2 Study of D-4517.2 for the Treatment of Wet AMD and DME
– First patient was enrolled as part of a two-stage Phase 2 study evaluating Ashvattha’s…
Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer
WALTHAM, Mass. and SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global…
89bio to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
SAN FRANCISCO, Sept. 07, 2022 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and Tyme
BEDMINSTER, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Tyme Technologies, Inc. (NASDAQ:TYME) (“Tyme” or the…
Tempest to Present at the H.C. Wainwright 24th Annual Global Investment Conference
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Candel Therapeutics Announces Two Executive Leadership Appointments
Jason A. Amello joins Candel as Chief Financial Officer Garrett Nichols, MD, MS, joins Candel…
Elicio Therapeutics Announces Publication of Preclinical Data on ELI-005, a Lymph Node-Targeted Amphiphile Vaccine Against SARS-CoV-2
Data published in bioRxiv shows ELI-005 administration safely promotes robust cellular and humoral immunity through…
Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”)…
Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
MORRISTOWN, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical…
Eyenovia to Present at Upcoming Healthcare Conferences
NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (Nasdaq: EYEN), a clinical stage…
Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics
New name, logo, website, and branding reflect the Company’s strategic shift toward developing potentially groundbreaking…